Literature DB >> 25243550

Relevance of the ISGLS definition of posthepatectomy liver failure in early prediction of poor outcome after liver resection: study on 680 hepatectomies.

Cécile Skrzypczyk1, Stéphanie Truant, Alain Duhamel, Carole Langlois, Emmanuel Boleslawski, Dine Koriche, Mohamed Hebbar, François Fourrier, Philippe Mathurin, François René Pruvot.   

Abstract

OBJECTIVE: To assess the relevance of the International Study Group of Liver Surgery (ISGLS) definition of posthepatectomy liver failure compared with 2 well-established criteria, 50-50 and PeakBili>7, as early predictors of posthepatectomy outcome.
BACKGROUND: There is limited data on the postoperative use of ISGLS definition of posthepatectomy liver failure as early predictor of outcome.
METHODS: Between 2007 and 2012, a total of 680 hepatectomies were analyzed from a prospective database. The value of each definition for prediction of 3-month major complications (Clavien III-V) and mortality was assessed either within 10 days of surgery or on postoperative day 5.
RESULTS: Three-month major morbidity and mortality rates were 16.5% and 4.4%, respectively. Within 10 days, 79 patients fulfilled ISGLS definition compared with 24 for 50-50 and 44 for PeakBili>7 criteria. Sensitivities of ISGLS definition and 50-50 and PeakBili>7 criteria for prediction of major morbidity and mortality were 35.8, 17.4, 24.8% and 56.7, 36.7, 56.7%, respectively. Patients with no positive score had a risk of death or major complication below 5% and 15%, respectively. In patients with a positive score, the ISGLS definition was the least relevant to predict major complications and mortality (positive predictive values of 49.4% and 21.8% vs 79.2% and 47.8% for 50-50 and 61.4% and 40.5% for PeakBili>7 criteria). The relative risk of death was 6.9 (95% confidence interval, 3.1-15.4) if the ISGLS definition was evaluated on postoperative day 5 versus 21.1 (95% confidence interval, 7.7-57.7) for 50-50 and 21.7 (95% confidence interval, 7.4-63.3) for PeakBili>7 criteria.
CONCLUSIONS: ISGLS definition was less discriminatory than 50-50 and PeakBili>7 criteria in identifying patients at risk of posthepatectomy major complications or death.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25243550     DOI: 10.1097/SLA.0000000000000944

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  19 in total

1.  Predictive Ability of Preoperative PT-INR and Postoperative MCP1 for Post-hepatectomy Liver Failure.

Authors:  Sayaka Arisaka; Ryusei Matsuyama; Koki Goto; Yusuke Suwa; Ryutaro Mori; Daisuke Morioka; Masataka Taguri; Itaru Endo
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 2.  Defining Post Hepatectomy Liver Insufficiency: Where do We stand?

Authors:  Kelly Lafaro; Stefan Buettner; Hadia Maqsood; Doris Wagner; Fabio Bagante; Gaya Spolverato; Li Xu; Ihab Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-06-11       Impact factor: 3.452

3.  Validation of the peak bilirubin criterion for outcome after partial hepatectomy.

Authors:  Kim M C van Mierlo; Toine M Lodewick; Dipok K Dhar; Victor van Woerden; Ralph Kurstjens; Frank G Schaap; Ronald M van Dam; Soumil Vyas; Massimo Malagó; Cornelis H C Dejong; Steven W M Olde Damink
Journal:  HPB (Oxford)       Date:  2016-07-02       Impact factor: 3.647

4.  Major hepatic resection: from volumetry to liver scintigraphy.

Authors:  François-René Pruvot; Stéphanie Truant
Journal:  HPB (Oxford)       Date:  2016-09       Impact factor: 3.647

5.  Central hepatectomy: A valuable option to avoid posthepatectomy liver insufficiency in patients requiring extensive liver resection.

Authors:  Mehmet Fatih Can; Murat Urkan; Emin Lapsekili; Rahman Şenocak; Ümit Alakuş
Journal:  Turk J Surg       Date:  2017-12-01

6.  Surgical treatment of perihilar cholangiocarcinoma: early results of en bloc portal vein resection.

Authors:  Víctor Molina; Jaime Sampson; Joana Ferrer; Alba Díaz; Juan Ramon Ayuso; Santiago Sánchez-Cabús; Josep Fuster; Juan Carlos García-Valdecasas
Journal:  Langenbecks Arch Surg       Date:  2016-12-23       Impact factor: 3.445

7.  The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study.

Authors:  Simone Famularo; Matteo Donadon; Federica Cipriani; Francesco Ardito; Maurizio Iaria; Francesca Carissimi; Pasquale Perri; Tommaso Dominioni; Matteo Zanello; Simone Conci; Sarah Molfino; Fabrizio D'Acapito; Paola Germani; Cecilia Ferrari; Stefan Patauner; Enrico Pinotti; Ivano Sciannamea; Marco Garatti; Enrico Lodo; Albert Troci; Antonella Delvecchio; Antonio Floridi; Davide Paolo Bernasconi; Luca Fumagalli; Marco Chiarelli; Riccardo Memeo; Michele Crespi; Giacomo Zanus; Giuseppe Zimmitti; Adelmo Antonucci; Mauro Zago; Antonio Frena; Guido Griseri; Paola Tarchi; Giorgio Ercolani; Gian Luca Baiocchi; Andrea Ruzzenente; Elio Jovine; Marcello Maestri; GianLuca Grazi; Raffaele Dalla Valle; Felice Giuliante; Luca Aldrighetti; Fabrizio Romano; Guido Torzilli
Journal:  J Gastrointest Surg       Date:  2021-03-09       Impact factor: 3.452

8.  Improving the quality of liver resection: a systematic review and critical analysis of the available prognostic models.

Authors:  Chetana Lim; Cornelius H Dejong; Oliver Farges
Journal:  HPB (Oxford)       Date:  2014-10-17       Impact factor: 3.647

9.  Liver Stiffness Assessed by Shear Wave Elastography Predicts Postoperative Liver Failure in Patients with Hepatocellular Carcinoma.

Authors:  Yinghao Shen; Chenhao Zhou; Guodong Zhu; Guoming Shi; Xiaodong Zhu; Cheng Huang; Jian Zhou; Jia Fan; Hong Ding; Ning Ren; Hui-Chuan Sun
Journal:  J Gastrointest Surg       Date:  2017-05-16       Impact factor: 3.452

10.  Preoperative Cholangitis and Future Liver Remnant Volume Determine the Risk of Liver Failure in Patients Undergoing Resection for Hilar Cholangiocarcinoma.

Authors:  Dario Ribero; Giuseppe Zimmitti; Thomas A Aloia; Junichi Shindoh; Forchino Fabio; Marco Amisano; Guillaume Passot; Alessandro Ferrero; Jean-Nicolas Vauthey
Journal:  J Am Coll Surg       Date:  2016-02-13       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.